Bristol-Myers Squibb Co (NYSE:BMY) and Pfizer Inc. (NYSE:PFE) have announced the first patient has been enrolled into a Phase IV clinical trial…
Browsing: BioPharma
284
Bristol-Myers Squibb Co (NYSE:BMY), Pfizer Inc. (NYSE:PFE) Enroll Patients In Phase IV Trial Of Eliquis
265
Pharma Stocks in News: La Jolla Pharmaceutical Co. (NASDAQ:LJPC), Geron Corporation (NASDAQ:GERN), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA),
The shares of La Jolla Pharmaceutical Co. (NASDAQ:LJPC) surged by 17.10 percent and reached the value of $12.70. On July…
18
Pharma Stock Updates: Pfizer Inc. (NYSE:PFE), Avanir Pharmaceuticals Inc (NASDAQ:AVNR), OncoMed Pharmaceuticals Inc (NASDAQ:OMED)
Pharmaceutical giant, Pfizer Inc. (NYSE:PFE), said it agreed to buy closely held generic drugmaker Innopharma for $225 million in upfront cash…
799
Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) Initiates $5 Million Registered Direct Offering
Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI), a holding company engaged in the research, development, production, marketing, and sales of veterinary healthcare and medical…
745
Exelixis (NASDAQ:EXEL) Comes up with Positive Results for its Study of Phase 3 of Cobimetinib Drug
Exelixis, Inc. (NASDAQ:EXEL) is a biopharma company that is committed to the development and commercialization of therapies for treating cancer.…
11
Pharma Stocks to Watch: BSD Medical Inc. (NASDAQ:BSDM), Nymox Pharmaceutical Corporation (NASDAQ:NYMX)
BSD Medical Inc. (NASDAQ:BSDM) which provides systems that use heat therapy to treat cancer, said it has begun a Phase I/II…